News

Conducted on 15 healthy volunteers at Linear Clinical Research’s facility in Perth, Australia, the study validated additional pharmacokinetic parameters associated with the safety and elimination profile that remained

The retinal device will be offered to late-stage retinitis pigmentosa (RP) patients in six German university clinics and teaching hospitals. Retina Implant CEO Walter-G Wrobel said: "Since receiving

Sanofi and Mannkind have signed an exclusive licensing agreement to develop and market the latter’s inhaled insulin diabetes therapy Afrezza. Under the terms of the agreement, France-based Sanofi

The Economic Times has reported that the drug company is likely to introduce its generic drugs in Japan in three to four years after the deal with Ranbaxy

The vaccine is being developed by GSK in collaboration with scientists at the US National Institute of Allergy and Infectious Diseases (NIAID). In primates, the vaccine has already

On January 9, 2014, Avillion announced it had entered into an exclusive collaborative development agreement with Pfizer Inc. to conduct a global Phase 3 clinical trial of BOSULIF.

The patent describes and claims a targeted drug delivery method that combines bacterial minicells and a "bispecific ligand" in a composition lacking undesirable contamination from parent bacterial cells

This approval represents the first ADASUVE approval in Latin America for Ferrer and Alexza. Ferrer is Alexza’s commercial partner for ADASUVE in the EU, Latin America and Commonwealth

This syringe technology developed under its product name "ChaSyr," (pronounced chaser), allows for the sequential administration of two separate intravenous (IV) medications with a single syringe, replacing multiple